marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Microbot Medical Balance Sheet 2011-2024 | MBOT
Annual Balance Sheet Microbot Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-2.24 M | -1.98 M | -12.8 M | -19.6 K | -27.9 M | -5.24 M | -10.8 M | -2.63 M | -1.78 M | -9.97 M | -17.6 M | -8.14 M | -12.8 M |
Long Term Debt |
40 K | 179 K | 402 K | - | - | - | - | 76 K | 8.92 M | 10.3 M | 9.24 M | 125 K | 331 K |
Long Term Debt Current |
191 K | 283 K | 278 K | 187 K | 143 K | - | - | - | - | - | 125 K | 206 K | 191 K |
Total Non Current Liabilities |
- | - | - | - | 760 K | 8 K | 528 K | 889 K | 11.7 M | 15.1 M | 17.5 M | 11.1 M | 8.83 M |
Total Current Liabilities |
3.79 M | 2.07 M | 1.98 M | 1.34 M | 4.83 M | 4.76 M | 528 K | 783 K | 173 K | 101 K | 9.13 M | 5.1 M | 5.65 M |
Total Liabilities |
3.83 M | 2.25 M | 2.39 M | 1.97 K | 5.59 M | 4.77 M | 1.06 M | 1.67 M | 21.6 M | 26.6 M | 26.6 M | 16.2 M | 14.5 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | 16.8 K | 16.8 K | 67.2 K | 74.4 K | 43.9 K |
Retained Earnings |
-79.5 M | -68.8 M | -55.6 M | - | -35.1 M | -27.9 M | -20.6 M | -13 M | -457 M | -420 M | -388 M | -361 M | -333 M |
Total Assets |
8.33 M | 9.54 M | 16.8 M | 26.3 K | 37.1 M | 6.09 M | 11 M | 3.37 M | 21.2 M | 32.4 M | 41.6 M | 30.2 M | 25.2 M |
Cash and Cash Equivalents |
2.47 M | 2.44 M | 13.5 M | 19.6 M | 28.8 M | 5.24 M | 10.8 M | 2.71 M | 437 K | 790 K | 359 K | 8.47 M | 13.3 M |
Book Value |
4.5 M | 7.29 M | 14.4 M | 24.3 K | 31.5 M | 1.32 M | 9.96 M | 1.7 M | -334 K | 5.87 M | 15 M | 14 M | 10.7 M |
Total Shareholders Equity |
4.5 M | 7.29 M | 14.4 M | 24.3 M | 31.5 M | 1.33 M | 9.96 M | 1.7 M | -64 K | 857 K | 375 K | 14 M | 10.7 M |
All numbers in USD currency
Quarterly Balance Sheet Microbot Medical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
29 K | 38 K | 17 K | 40 K | 39 K | 92 K | 127 K | 179 K | 226 K | 278 K | 386 K | 402 K | 436 K | 543 K | 565 K | 626 K | 626 K | 626 K | 626 K | 760 K | 760 K | 760 K | 760 K | - | - | - | - | - | - | - | 245 K | 76 K | 76 K | 76 K | 76 K | 419 K | - | - | - | - | - | - | - | - | - | 17.5 K | 71.2 K | 125 K | 125 K | 125 K | 125 K | 331 K | 331 K | 331 K | 331 K |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8 K | - | - | - | 28 K | - | - | - | 389 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.4 M | 1.38 M | 1.2 M | 3.83 M | 1.53 M | 1.42 M | 1.36 M | 2.25 M | 1.88 M | 2 M | 2.06 M | 2.39 M | 1.83 M | 1.75 M | 1.84 M | 1.97 M | 1.97 M | 1.97 M | 1.97 M | 5.59 M | 5.59 M | 5.59 M | 5.59 M | 4.76 M | 4.76 M | 4.76 M | 4.76 M | 556 K | 556 K | 556 K | 556 K | 1.17 M | 1.17 M | 1.17 M | 1.17 M | 419 K | 21.6 M | 21.6 M | 21.6 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.8 K | 16.8 K | 16.8 K | 16.8 K | 16.8 K | 16.8 K | 16.8 K | 16.8 K | 16.8 K | 16.8 K | 16.8 K | 67.2 K | 67.2 K | 67.2 K | 67.2 K | 74.4 K | 74.4 K | 74.4 K | 74.4 K | 43.9 K | 43.9 K | 43.9 K | 43.9 K |
Retained Earnings |
-87.6 M | -84.3 M | -81.9 M | -79.5 M | -76.3 M | -73.9 M | -71.6 M | -68.8 M | -65.8 M | -62.3 M | -58.8 M | -55.6 M | -51.7 M | -49.2 M | -46.7 M | -44.3 M | -44.3 M | -44.3 M | -44.3 M | -35.1 M | -35.1 M | -35.1 M | -35.1 M | -27.9 M | -27.9 M | -27.9 M | -27.9 M | -20.6 M | -20.6 M | -20.6 M | -20.6 M | -13 M | -13 M | -13 M | -13 M | -3.37 M | -457 M | -457 M | -457 M | -2.45 M | -420 M | -420 M | -420 M | -388 M | -388 M | -388 M | -388 M | -361 M | -361 M | -361 M | -361 M | -333 M | -333 M | -333 M | -333 M |
Total Assets |
5.21 M | 7.43 M | 7.37 M | 8.33 M | 8.89 M | 10.9 M | 6.21 M | 9.54 M | 7.41 M | 10.5 M | 13.7 M | 16.8 M | 19.7 M | 21.9 M | 24.2 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 37.1 M | 37.1 M | 37.1 M | 37.1 M | 6.09 M | 6.09 M | 6.09 M | 6.09 M | 11 M | 11 M | 11 M | 11 M | 3.37 M | 3.37 M | 3.37 M | 3.37 M | 529 K | 21.2 M | 21.2 M | 21.2 M | 958 K | 32.4 M | 32.4 M | 32.4 M | 41.6 M | 41.6 M | 41.6 M | 41.6 M | 30.2 M | 30.2 M | 30.2 M | 30.2 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M |
Cash and Cash Equivalents |
479 K | 2.46 M | 1.16 M | 2.47 M | 1.34 M | 5.72 M | 2.15 M | 2.44 M | 4.33 M | 7.29 M | 10.5 M | 13.5 M | 13.4 M | 15.6 M | 17.9 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 2.71 M | 2.71 M | 2.71 M | 2.71 M | 437 K | 12.1 M | 12.1 M | 12.1 M | 791 K | 25 M | 25 M | 25 M | 359 K | 30.6 M | 30.6 M | 30.6 M | 8.47 M | 8.47 M | 8.47 M | 8.47 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M |
Book Value |
3.81 M | 6.06 M | 6.17 M | 4.5 M | 7.36 M | 9.47 M | 4.85 M | 7.29 M | 5.53 M | 8.54 M | 11.6 M | 14.4 M | 17.9 M | 20.1 M | 22.3 M | 24.3 M | 24.3 M | 24.3 M | 24.3 M | 31.5 M | 31.5 M | 31.5 M | 31.5 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 110 K | -334 K | -334 K | -334 K | -25.6 M | 5.87 M | 5.87 M | 5.87 M | 15 M | 15 M | 15 M | 15 M | 14 M | 14 M | 14 M | 14 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M |
Total Shareholders Equity |
3.81 M | 6.06 M | 6.17 M | 4.5 M | 7.36 M | 9.47 M | 4.85 M | 7.29 M | 5.53 M | 8.54 M | 11.6 M | 14.4 M | 17.9 M | 20.1 M | 22.3 M | 24.3 M | 24.3 M | 24.3 M | 24.3 M | 31.5 M | 31.5 M | 31.5 M | 31.5 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 9.99 M | 9.96 M | 9.96 M | 9.96 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | -64 K | -334 K | -334 K | -334 K | 857 K | 5.87 M | 5.87 M | 5.87 M | 375 K | 15 M | 15 M | 15 M | 14 M | 14 M | 14 M | 14 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M |
All numbers in USD currency